lawsuit tirzepatide Eli Lilly sues Mochi Health and others for 'deceptive' marketing Trulicity Lawsuit [2026] | Stomach

Coverage Baseline Previously unavailable under Medicare Part D Only 13 states cover them in Medicaid (KFF HMA survey) 19% of large employers cover GLP-1s for obesity, though 43% of employers with 5,000+ employees offer coverage (KFF 2025 survey) Current Expansion ~50% of CVS Caremark clients now provide coverage for weight loss Medicare GLP-1 Bridge program launches coverage for eligible Medicare Part D patients 7/1/26 This aligns with a recent survey from Business Group on Health that found 67% of the surveyed employers now cover GLP-1s for weight loss (though a reduction is expected for 2027)

Shed It

MedTech stocks continue to feel pressure from glucagon-like peptide-1 (GLP-1) drugs for obesity, based primarily on speculation, and despite strong third-quarter performances from many firms in this sector

Weight loss triggered by semaglutide often leads to improved sleep patterns, reduced sleep apnea symptoms, and better overall rest quality

Appearance: White to off-white lyophilised powder

Learn about how this medication may affect fertility and getting pregnant on Ozempic.